Accepting patients in the Urology medical unit of Florya Hospital, Prof. Dr. Semih Ayan completed his education at Sivas Cumhuriyet University Faculty of Medicine in 1997 and received the title of Urology Specialist. In 1999, he became a Postdoctoral Fellow in Pediatric Urology at Harvard University; He became Associate Professor of Urology in 2003 and Professor of Urology in 2009. In 2015, he completed his Minimal Invasive Urological Oncology (Clinical Fellow) studies at the University of Chicago and crowned his professional education and experience with international studies.

In the field of Urological Oncology, which is one of the physician's areas of interest, surgical treatment of prostate cancer, bladder cancer and kidney tumors provides a significant increase in the survival rate and the chance of surviving cancer. In the field of Pediatric Urology, which is another area of interest, congenital anomalies such as renal outflow stenosis, urinary reflux to the kidney and hypospadias are corrected by using innovative surgical applications and a lifelong contribution is provided to the patients.

Medical equipment required for medical diagnosis, treatment and surgical treatment to be given in the areas specified in our urology units, laparoscopic surgeries and all kinds of equipment suitable for the use of new surgical techniques are available in our hospital. With the treatment and operations performed in our hospitals by making use of the best facilities offered by medical technology, a significant increase in the quality of life is achieved while the patients are healed.

prof. Dr. Semih Ayan received almost all of his medical education and certificates from the leading institutions of America and Europe, and gained deep knowledge and international experience in many advanced specialties of urology. prof. Dr. Among the trainings and certificates Ayan has received internationally;

American Medical License (USML)

Pediatric Urology Fellow (1999-2000/Boston, USA)

Urological Oncology Fellow (2014-2015/USA).

Prof. Dr. Abdulmuttalip Şimşek

Prof. Dr. Abdulmuttalip Şimşek graduated from Istanbul University Faculty of Medicine in 2005. In 2010, he completed his 'Specialization Training' in the field of Urology at Foundation Gureba Hospital. Prof., who conducts studies at Istanbul Faculty of Medicine, Lütfiye Nuri Burat State Hospital and Haseki Training and Research Hospital. Dr. Abdulmuttalip Şimşek received the title of Associate Professor in 2015.

He carried out studies at the University of Sheffield and Hallamshire Hospital between 2015 and 2016. Returning to Turkey in 2016, Prof. worked as a teaching assistant at Bakırköy Sadi Konuk Training and Research Hospital. Dr. Abdulmuttalip Şimşek has been working as a urologist at Başakşehir Çam and Sakura Hospital since 2020.

Prof. has an innovative perspective in the field of urology. Dr. Abdulmuttalip Şimşek treats his patients by taking advantage of developing technology. Prof. has made significant contributions to the field of urology with many international research and scientific publications. Dr. Abdulmuttalip Şimşek treats his patients as a Robotic and Reconstructive Urology Specialist.

Education status:

Degree

Department/Program

University

Year

Undergraduate Medicine Istanbul University, Istanbul Faculty of Medicine, Istanbul 1999-2005

Specialization in Medicine Urology Bezmi Alem Vakif University Faculty of Medicine, Istanbul 2005-2010

Associate Professorship SBU Haseki Training and Research Hospital 2015

PhD in Reconstructive Urology under the direction of Professor Christopher Chapple, University of Sheffield and Hallamshire Hospital, England 2015-2016

Medical Specialization Thesis Title and Advisor: Comparison of Efficacy and Complication Rates of Transobturator and Retropubic Midurethral Loose Sling Surgery in Stress Urinary Incontinence Patients (2010) Thesis Advisor: Prof.Dr. Sinasi Yavuz Önol Bezmi Alem Vakıf University Faculty of Medicine Urology Clinic

Areas of Interest: Reconstructive urology, Robotic surgery, Urooncology

Tasks:

Job Title

Duty Station

Year

Expert Dr. Lütfiye Nuri Burat State Hospital – Istanbul 2011- 2012

Expert Dr. Haseki Training and Research Hospital Urology Clinic - Istanbul 2012 January - 2015

Assoc. Dr. Haseki Training and Research Hospital Urology Clinic - Istanbul 2015

Associate Professor. University of Sheffield and Hallamshire Hospital, England 2015-2016

Education Officer Bakırköy Dr. Sadi Konuk Training and Research Hospital Urology Clinic - Istanbul 2016 – May 2020

Education Officer Başakşehir Çam and Sakura City Hospital Urology Clinic - Istanbul 2020 June - Present

Administrative Duties:

Bakırköy Dr. Sadi Konuk Training and Research Hospital Urology Clinic Administrative Manager – 2020

Supervised Theses:

expertise in medicine

Yunus ÇOLAKOĞLU (2020). Comparison of oncological and functional results of Robotic and Open Perineal Radical Prostatectomy. University of Health Sciences, Bakırköy Dr. Sadi Konuk Training and Research Hospital Urology Clinic

Ramazan UĞUR (2020). The effect of end-to-end anastomosis urethroplasty and buccal mucosal graft urethroplasty techniques on erectile function in bulbar urethra stenosis. University of Health Sciences, Bakırköy Dr. Sadi Konuk Training and Research Hospital Urology Clinic

Abdullah Hızır YAVUZSAN (2017). Comparison of peroperative parameters according to renal nephrometry score in robotic and laparoscopic partial nephrectomies. University of Health Sciences, Bakırköy Dr. Sadi Konuk Training and Research Hospital Urology Clinic

Memberships to Scientific Organizations:

Turkish Urology Association

Turkish Andrology Association

European Association of Urology

American Urological Association

American Society of Genitourinary Reconstructive Surgery

Awards :

Alpay KELAMI, Men's Sexual Health award, Turkish Andrology Association, 2011

Men's Sexual Health Alpay KELAMI award, Turkish Andrology Association, 2009

Dr. Saban Sec is a medical oncologist with experience at leading hospitals, including Haseki Training and Research Hospital, Prof. Dr. Cemil Taşcıoğlu City Hospital, and Bahçelievler Medikalpark Hospital. He currently represents specialist physicians in the Turkish Medical Oncology Association. He is also a member of the Istanbul Medical Chamber and the Turkish Medical Oncology Association.

Dr. Sec treats breast, lung, gastrointestinal, prostate, urogenital, head and neck cancers, as well as sarcomas and rare tumors. He has published many peer-reviewed articles on cancer prognosis, treatment outcomes, and survival rates. His research includes studies with large patient groups, such as 138 patients with HER2-positive metastatic gastric cancer. Dr. Sec focuses on prognostic factors and treatment responses in different cancers. He is dedicated to improving cancer care.

Under his leadership, the hospital is actively expanding its services, including paediatric cardiology and intensive care, and is planning to establish an interdisciplinary center for parents and children on the basis of the Department of Paediatrics.

Dr. Propson's many years of experience have established him as a leading expert in neonatology and paediatric cardiology in Germany and Europe. His dedication and commitment to the highest level of care for young patients is reflected in his work. Dr. Propson's research and scientific publications demonstrate his in-depth knowledge and commitment to development in paediatrics.

For many years Dr. Propson worked as a leading physician in the Department of Paediatrics and Adolescent Medicine at the Leverkusen Clinic in Leverkusen, Germany, where he was also responsible for managing the paediatric intensive care unit. In addition to his primary work, Dr. Propson devotes a great deal of time to continuing education to ensure that his patients receive the most up-to-date treatments in his department.

His unique professional qualities and qualifications set him apart from other physicians. Dr. Propson's patients can rest assured that they are in good hands at the Department of Paediatrics and Adolescent Medicine at the Academic Hospital Solingen.

Membership in societies:

German Association of Physicians

Expert of scientific journals

Specialisations:

Emergency medicine

Intensive care

Paediatric cardiology

Neonatology

Work Experience:

2006: Graduation from the Faculty of Medicine

2006 - 2011: Specialization as a specialist in paediatrics and adolescent medicine.

2011 - 2023: Lead physician in the Department of Paediatrics and Adolescent Medicine at the Leverkusen Clinic.

2023: Chief physician in the Department of Paediatrics at the Academic Hospital Solingen.

Assist. Op.Dr.Oğuzhan Parlakkılıç graduated from Atatürk University Faculty of Medicine in 2001.

He started his specialization in the urology clinic of Taksim Training and Research Hospital in 2002. Having completed his specialization training in 2007, Dr. Oğuzhan Parlakkılıç attended many national and international meetings. He has studies in andrology, endourology and urooncology.

Between 2007 and 2009, he completed his duty of public service obligation at Sivelek State Hospital.

Between 2009 and 2010, he worked as a urology specialist in the General Command of Mapping Dispensary. 

ハイム・マツキン教授は、腫瘍学、泌尿器学そして外科の分野で著名なイスラエルの専門家です。医師はソウラスキー医療センターの泌尿器科を率いており、広範囲の性器尿路系疾患（悪性腫瘍を含む）の治療を専門としています。

ハイム・マツキン教授は、小線源治療の応用における認められた権威 （放射線治療が悪性細胞のみに影響を及ぼす）および凍結療法（低温で腫瘍細胞に影響を及ぼす）です。

医師は、次のような組織の正式なメンバーです：

• イスラエル医師会；
• ヨーロッパ、アメリカ合衆国、イスラエルの泌尿器科医協会。

この医師は結腸直腸、膵臓、および消化器外科を専門としており、特にウィップル手術において専門知識を持っています。45年以上の実績を持ち、この医師はイスラエルで最も著名なウィップル手術の外科医の一人として認識されています。

Univ. Prof. Dr. ウォルフガング・ケストラーは、オーストリアの著名な医学的腫瘍学者および内科医であり、乳がん、婦人科悪性腫瘍、および標的がん治療の専門知識で国際的に認められています。臨床、学術、研究の経験が20年以上にわたり、彼はオーストリアにおける個別化がん治療の最前線の権威の一人となりました。

彼はウィーン大学で医学を学び、1990年代に卒業し、その後ウィーン医科大学で内科および医学的腫瘍学のレジデンシーを修了しました。キャリアの初期には、彼は先進的な腫瘍学者と共に標的療法と個別化医療の開発に従事し、これは後の彼の多くの研究に影響を与える分野となりました。

   1990年代 – ウィーン総合病院（AKH）での内科および腫瘍学の研究およびレジデンシーを修了しました。

   2000年代 – 固形腫瘍腫瘍学に特化し、乳がんや婦人科がんに焦点を当て、標的療法に関する初期の臨床試験に貢献しました。

   2010年代 – ウィーン医科大学の准教授および腫瘍学の臨床部門の副主任に任命され、分子腫瘍学の推進に貢献しました。

   現在 – ウィーン私立クリニックで上級コンサルタントとして勤務し、ウィーン医科大学での学術活動を続け、個別化された全身がん治療、免疫療法、および転位がん研究に注力しています。

ケストラー教授の研究関心には、バイオマーカーの開発、腫瘍生物学、および標的薬剤への耐性メカニズムが含まれており、正確な腫瘍学における新しい治療戦略の設計に貢献しています。彼の科学研究は主要な国際雑誌に掲載されており、彼はヨーロッパの腫瘍学ネットワークに積極的に参加し続けています。

診断の正確さ、臨床的共感、革新的な考え方で知られるケストラー教授は、科学的進歩と慈悲深い患者ケアを組み合わせた個別化がん医学の未来を体現しています。

この医師は、低侵襲手術およびロボット手術において豊富な経験を持つ、ボード認定の外科医です。これらの先進的な外科技術を専門とし、Sourasky Medical Centerで診療を行い、患者の治療結果を改善するためにその専門知識を活用しています。

アビ・ベリ先生は、サラッキ医療センターの著名な医師であり、海外での割礼、腎結石治療、前立腺切除術、前立腺経尿道的切除術（TURP）、泌尿器科相談、海外でのパイプカットに専門があります。彼は様々な泌尿器関連の病状に対して包括的な治療を提供し、患者が健康な生活に戻るのを支援します。

• 海外での割礼、腎結石治療、前立腺切除術、前立腺経尿道的切除術（TURP）、泌尿器科相談、海外でのパイプカットに専門があります
• 患者が健康な生活に戻るのを支援します
• 様々な泌尿器関連の病状に対して包括的な治療を提供します

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020

Prof. Dr. Özgür Haki Yüksel - Specialist in Urology

Education and Specialization:

• Medical Degree: Ankara University Faculty of Medicine (2003)
• Residency in Urology: Haydarpaşa Numune Training and Research Hospital (2003-2008)
• Advanced Training: Clinical observership at the University of Michigan, Department of Urology, Ann Arbor, MI, USA under Prof. J. Stuart Wolf (2015)

Professional Experience:

• 2003-2008: Urology Residency at Haydarpaşa Numune Training and Research Hospital
• 2009-2010: Military Service
• 2010-2018: Urology Specialist at Fatih Sultan Mehmet Training and Research Hospital
• 2018-Present: Professor and Urology Specialist at VM Medical Park Pendik Hospital
• 2018-Present: Faculty Member at Bahçeşehir University Faculty of Medicine, Department of Urology

Areas of Expertise:

• Urological Oncology
• Endourology (Laparoscopy, Robotic Surgery)
• Stone Diseases
• Urogynecology (Urinary Incontinence)
• Andrology (Infertility)

Research and Publications: Prof. Dr. Yüksel has contributed to 12 national and 34 international publications, including editorials, case reports, reviews, and original articles. He has also presented 16 international and 30 national conference papers and contributed to chapters in two national books.

Certifications and Awards:

• FEBU Board Certification, recognized across European countries for urology specialization
• Numerous certifications from national and international courses and congresses, including the European Board of Urology oral and written exams

Professional Memberships:

• Turkish Urology Association
• European Urology Association (EAU)

Assoc. Prof. Cevper Ersöz, M.D.

Urology
 

Areas of Expertise and Interest

• Urological Cancers (Robotic & Laparoscopic Surgery)
• Stone Diseases (PCNL, URS)
• Benign Prostate Hyperplasia (HoLEP, TuLEP, Rezum®)
• Minimally Invasive Prostate Treatments (TUR-P, Robotic)
• Kidney, Bladder, Testis Diseases
• Sexual Dysfunction & Infertility
• Urological Infections

Education and Career

• M.D. (Doctor of Medicine): Istanbul University, Istanbul Faculty of Medicine (2006)
• Residency in Urology (Specialist Training): Bezmialem Vakıf University, Istanbul (2012)
• Associate Professorship in Urology: Bezmialem Vakıf University, Istanbul (2015)

Certificates

• Fellow of the European Board of Urology (FEBU)
• Observership in Urologic Surgery, University of Michigan, Ann Arbor, USA (2011)
• Advanced Training in Robotic and Laparoscopic Surgery

Memberships in Scientific Organizations

• Turkish Urology Association
• Turkish Pediatric Urology Association
• Turkish Endourology Society
• European Association of Urology (EAU)
• European Society of Endourology

Publications

• Author of 130+ national and international peer-reviewed scientific publications.
• Research focus: Endourology, urologic oncology, andrology, and minimally invasive surgery.
• Contributions include book chapters and numerous conference presentations.

Awards Received

• Male Sexual Health – Alpay Kelami Award (2009): Recognized for innovative andrology research.
• 22nd National Urology Congress Recognition (2012): Acknowledged for surgical technique studies.

Education & Expertise

• 1998 to 2004 – Istanbul University, Istanbul Faculty of Medicine
• 2005 to 2009 – Düzce University, Internal Medicine Specialization
• 2009 to 2010 – Beytüşşebap State Hospital, Compulsory Internal Medicine Service
• 2010 to 2013 – Bülent Ecevit University, Medical Oncology Specialization
• 2013 to 2015 – Recep Tayyip Erdoğan University, Medical Oncology Compulsory Service
• 2015 to Present – Associate Professor, Recep Tayyip Erdoğan University
• 2015 to 2021 – Lecturer, Medical Oncology, Sakarya University Faculty of Medicine
• 2020 to Present – Professor, Sakarya University Faculty of Medicine
• 2020 to Present – Ph.D. Student, Inorganic Chemistry, Sakarya University

Experience

• 2008 – Cleveland Clinic, Rheumatology & Gastroenterology Rotation
• 2016 to 2017 – Northeastern University, The Center for Pharmaceutical Biotechnology and Nanomedicine, Boston, U.S.

Professional Memberships

• TTOD (Turkish Society of Medical Oncology)
• ASCO (American Society of Clinical Oncology)
• ESMO (European Society for Medical Oncology)

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.

Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.

5. Academic Appointments:

Appointed as Faculty Member: 28.03.2022

Associate Professorship: ---

Full Professorship: ---

6. Supervised Theses:

Master's Theses: None listed

Doctoral Theses: None listed

7. Publications:

7.1. Articles Published in International Peer-Reviewed Journals (SCI, SSCI, Arts & Humanities):

"Urodynamic Curve Patterns May Predict Female Bladder Outlet Obstruction and Detrusor Underactivity." Urology, 2022. (Co-authored)

"Are Elevated Mitochondrial DNA Fragments in Prostatic Inflammation a Potential Biomarker for Prostate Cancer?" Archivio Italiano di Urologia e Andrologia, 2023. (Co-authored)

7.2. Articles Published in Other International Peer-Reviewed Journals:

"A Case Report of Pediatric High-Flow Priapism: The Management of a Rare Condition." European Journal of Medical Case Reports, 2021.

"Unusual Presentation of Classical Kaposi Sarcoma: Penile Involvement in an HIV Seronegative Patient." European Journal of Medical Case Reports, 2023.

7.3. Papers Presented at International Scientific Meetings:

Multiple presentations at international urology congresses. (Details available upon request.)

7.4. International Book Chapters:

Aferin U. "Approach to Muscle Invasive Bladder Cancer," in Current Perspective in Urooncology, Akademiyen Kitabevi, 2022. ISBN: 978-625-8259-52-0, p.147

7.5. Articles Published in National Peer-Reviewed Journals:

"Massive Inguinoscrotal Bladder Hernia and Bladder Tumor: A Very Rare Case." J Urol Surg, 2018.

"Testicular Torsion: Experience in a Tertiary Urology Referral Centre." Journal of Urological Surgery, 2021.

"Association Between Prostate Biopsy Results and Serum Vitamin D Levels." Bulletin of Urooncology, 2021.

"Surgical Treatment in Localized Prostate Cancer." Cancer Agenda Journal, 2022.

7.6. Papers Presented at National Scientific Meetings (with Proceedings):

Participated and presented in multiple national urological congresses on topics including penile plication, robotic nephrectomy, and pediatric urological conditions. (Full list available upon request.)